“…[1][2][3][4][5] However, there are still many key technical issues, such as poor solubility of the drugs, low bioavailability, side-effects, poor therapeutic effect and serious toxicities, to limit the further study and clinical applications. [6][7][8][9][10] In order to address these challenges, more and more polymeric vectors, such as nanoparticles, 11-13 liposomes [14][15][16] and nano-scale carriers, [17][18][19] have been developed by many researchers around the world. Among these novel drug vehicles, polymeric micelles which are generally self-assembled by amphiphilic polymers with hydrophilic and hydrophobic segments show many advantages, including high drug loading capacity, small particle size (<200 nm), controlled release behavior and easily modied.…”